
ATNF
180 Life Sciences Corp
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
3.4094
Open
2.800
VWAP
2.87
Vol
16.55M
Mkt Cap
1.43M
Low
2.325
Amount
47.52M
EV/EBITDA(TTM)
--
Total Shares
941.59K
EV
1.72M
EV/OCF(TTM)
--
P/S(TTM)
--
180 Life Sciences Corp. is a biotechnology company, which focuses on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis. Its programs include Anti-TNF (Clinical), Synthetic Cannabinoid Analogs (SCAs), and a7nAChR (Preclinical). The Company also operates a back-end technology platform to operate an online blockchain casino.
Show More
Valuation Metrics
The current forward P/E ratio for 180 Life Sciences Corp (ATNF.O) is -0.01, compared to its 5-year average forward P/E of -18.85. For a more detailed relative valuation and DCF analysis to assess 180 Life Sciences Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-18.85
Current PE
-0.01
Overvalued PE
43.47
Undervalued PE
-81.18
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
3.37
Current PS
0.36
Overvalued PS
14.38
Undervalued PS
-7.63
Financials
Annual
Quarterly
FY2025Q1
YoY :
+13.41%
-2.37M
Operating Profit
FY2025Q1
YoY :
+121.48%
-2.37M
Net Income after Tax
FY2025Q1
YoY :
-60.12%
-0.67
EPS - Diluted
FY2025Q1
N/A
Free Cash Flow
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ATNF News & Events
Events Timeline
2025-07-01 (ET)
2025-07-01
07:49:36
180 Life Sciences announces grants of two patents

2025-05-01 (ET)
2025-05-01
09:37:55
180 Life Sciences announces notice of allowance for U.S. patent

2025-04-30 (ET)
2025-04-30
08:55:21
180 Life Sciences to repurchase 1.32M shares from Elray for $1M

Sign Up For More Events
Sign Up For More Events
News
2.0
07-21BenzingaWhy Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
9.5
07-18BenzingaWhy Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
9.5
05-23BenzingaWhy Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Sign Up For More News
People Also Watch

ALLR
Allarity Therapeutics Inc
1.020
USD
0.00%

STKH
Steakholder Foods Ltd
1.045
USD
-4.13%

AYRO
AYRO Inc
7.040
USD
-0.85%

ZAPP
Zapp Electric Vehicles Group Ltd
0
USD
-86.56%

CTHR
Charles & Colvard Ltd
0
USD
-8.16%

SONN
Sonnet Biotherapeutics Holdings Inc
3.990
USD
-5.45%

QNRX
Quoin Pharmaceuticals Ltd
8.170
USD
-4.50%

YOSH
Yoshiharu Global Co
8.340
USD
+2.96%

SYRA
Syra Health Corp
0
USD
-22.05%

KXIN
Kaixin Holdings
0.817
USD
+0.74%
FAQ

What is 180 Life Sciences Corp (ATNF) stock price today?
The current price of ATNF is 3 USD — it has increased 40.85 % in the last trading day.

What is 180 Life Sciences Corp (ATNF)'s business?

What is the price predicton of ATNF Stock?

What is 180 Life Sciences Corp (ATNF)'s revenue for the last quarter?

What is 180 Life Sciences Corp (ATNF)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for 180 Life Sciences Corp (ATNF)'s fundamentals?

How many employees does 180 Life Sciences Corp (ATNF). have?
